Definitive Contract HHSN268201600002C

Award Date 10/15/15
Potential Completion Date 10/14/20
Potential Value $7.6M
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Columbus, OH 43210, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the Women's Health Initiative (WHI) - Regional Center (RC) - Task Area A, awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. government. The $5,145,365.00 delivery order contract was awarded to The Ohio State University, a public research university, on October 15, 2020, with a period of performance through September 28, 2025. The contract has no set-aside designation. As a prominent research institution, The...
The U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a definitive cost-no-fee contract valued at $693,598.00 to The Ohio State University (OSU) on September 29, 2017. The contract, which does not have a set-aside designation, is for unspecified "other functions" and is scheduled for completion on March 31, 2019. OSU, through its Office of Sponsored Programs, has previously provided various goods and services to federal agencies,...
This is a firm fixed-price purchase order contract awarded by the Washington Headquarters Service, a defense agency, to The Ohio State University in the amount of $123,636.00. The contract is for graduate research support services and does not have a set-aside designation. The Ohio State University has a history of providing various goods and services to federal agencies, including coordination and support services for clinical trials related to women's health, infrastructure support for NASA...
This is a firm fixed-price delivery order awarded by the U.S. Department of Labor, Bureau of Labor Statistics to The Ohio State University for the National Longitudinal Survey Implementation. The $765,517.00 contract is for the provision of coordination and support services related to ongoing clinical trials and studies for the Women's Health Initiative. This order is part of a larger indefinite delivery contract the university holds with the National Institutes of Health National Heart, Lung...
This is a $60,364,446.48 definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health, to the Fred Hutchinson Cancer Research Center in Seattle, WA. The contract is for the Women's Health Initiative Clinical Coordinating Center, which provides core support services, DNA extraction, biorepository activities, clinical coordinating center services, and technical assistance for various research initiatives. This contract has no...
This is a $67,099.59 cost-no-fee purchase order contract awarded by the National Heart, Lung, and Blood Institute to the Fred Hutchinson Cancer Center for the Women's Health Initiative (WHI) program. The contract has no set-aside designation. The Fred Hutchinson Cancer Center, a non-profit medical research organization based in Seattle, Washington, will provide comprehensive services for the WHI, including clinical trial coordination, biorepository management, ancillary research support, and...
This is a federal contract award to Wake Forest University Health Sciences (WFUHS) by the National Heart Lung and Blood Institute, a part of the National Institutes of Health, for the Women's Health Initiative (WHI) Regional Center. The $4,266,302.00 cost-no-fee delivery order contract has a period of performance through September 28, 2025. WFUHS, a leading academic medical center, has extensive experience executing federal grants and contracts related to clinical trials, longitudinal health...
This is a $8,786,692.53 federal contract award from the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to Wake Forest University Health Sciences. The contract is for the "WOMEN HEALTH INITIATIVE - REGIONAL CENTER" and was awarded on October 15, 2015 with a final completion date of October 14, 2020. The contract is a Definitive Contract with a Cost No Fee pricing type, and was not set aside for any special program....
This is a federal contract award to the Fred Hutchinson Cancer Center (prime contractor) by the National Heart, Lung, and Blood Institute (NHLBI) for the Women's Health Initiative (WHI) Clinical Coordinating Center (CCC) - Task Area A. The contract has a potential ceiling value of $47,468,877 and does not have a set-aside designation. The contract involves the Fred Hutchinson Cancer Center providing comprehensive services for the WHI clinical trials and observational studies, including...
This federal contract award in the amount of $97,584.97 was issued by the Food and Drug Administration (FDA) to The Ohio State University. The award is part of the OARSA CONSORTIUM and has a period of performance ending on September 30, 2017. The contract is a firm fixed-price purchase order and does not have a set-aside designation. The Ohio State University has a history of providing various goods and services to federal agencies, including coordination and support services for clinical trials...

The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health, awarded a $7,629,643.88 definitive cost-no-fee contract to The Ohio State University (OSU) to serve as a Women's Health Initiative (WHI) Regional Center. The contract, which does not have a set-aside designation, tasks OSU with providing coordination and support services for ongoing WHI clinical trials and studies related to preventing heart disease, cancer, and fractures in postmenopausal women. The contract has a period of performance through October 2020, with the possibility of additional orders through October 2028 to continue this public health research under the $9 million contract vehicle.

Under the contract, OSU partners with the University of Pittsburgh and the University of Iowa as major subcontractors to leverage their expertise in women's health, cardiovascular disease, osteoporosis, and dementia research. These subcontracts support activities such as manuscript development, ancillary studies, and participant retention and outcomes documentation for the WHI trials.

Generated 12/5/24, 9:58 AM